We recently described a family with chromosome 17-linked dementia, characterized clinically by disinhibition-dementiaparkinsonism-amyotrophy complex. We report now the neuropathology of 6 affected family members. This included semiquantitative scoring of neuronal loss, gliosis, and spongiosis and immunocytochemical and ultrastructural characterization of neuronal and glial inclusions. The changes consisted of circumscribed neuronal loss, gliosis, and spongiosis of limbic neocortical areas and frontal, temporal, and occipital association areas. Similar changes were present in subcortical nuclei, most severe in the substantia nigra, but also involved the ventral striatum and amygdala. The hippocampus was spared except for degeneration of the afferent perforant tract, secondary to entorhinal nerve cell loss. hgyrophilic neuronal inclusions, with a characteristic immunocytochemical profile, were found in brainstem nuclei, hypothalamus, and basal ganglia. Ultrastructurally, in 3 patients these inclusions showed hitherto undescribed abnormally assembled filaments. Glial cytoplasmic inclusions were widespread in white matter structures. Immunocytochemistry failed to demonstrate the protease-resistant prion protein. The pathology appears to be unique, involving various cortical and subcortical structures, and is consistent with the clinical findings of Kliiver-Bucy-like syndrome, parkinsonism, and frontal lobe dementia. For this entity we suggest the term "chromosome 17-linked dementia."
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Sima AAF, Defendini R, Keohane C, D'Amato C, Foster NL, Parchi P, Gambetti P, Lynch T, Wilhelmsen KC. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996; 39:734-743 We recently reported a family in which 13 members had varying degrees of disinhibition, parkinsonism, dementia, and in some members, aniyotrophy. We suggested the name "disinhibition-dementia-parkinsonism-amyotrophy complex" [ 11. In 6 members from this family who underwent autopsy, the onset of obvious disease occurred at a mean age of 44 years. Initially, the patients showed a range of personality and behavioral changes. Disinhibition, a predominant feature, manifested as a Kluver-Bucy-like syndrome with hyperihyposexuality and oral tendency, alcoholism and aggressiveness. Social withdrawal, depression, and a schizophrenia-like picture occurred in some patients. These features were found in a variety of combinations and varied over time in individual patients. Memory was eventually affected in all, with relative preservation of orientation, speech, and calculation ability until late in the disease. Parkinsonism and cognitive deterioration led to a rigid, akinetic mute state. Amyotrophy was obvious in 1 patient. The mean duration of the disorder to death was 14 years.
A genetic etiology was suspected because of the familial clustering of the disorder. Linkage analysis by typing of simple sequence repeat polymorphisms in 33 family members localized the disease locus to 17q21-22 [l-31, the same locus to which familial progressive subcortical gliosis recentlywas linked 141. The disorder is transmitted as a highly penetrant autosomal dominant trait. As in other familial neurodegenerative disorders [5] [6] [7] [8] [9] , there appear to be sporadic forms with clinical and pathological phenotypes similar to the chromosome 17-linked disease reported here [3] . However, the genetic etiologic relationship of sporadic disease with a similar pathology to the present disease is unknown. We reviewed the pathological findings in all available members with familial disease to id en ti^ characteristic and consistent features that could be correlated with the clinical features of this disease [I] . 
Materials and Methods

Electron Microscopy
One-millimeter tissue cubes were cut from paraffin blocks from 3 family members (111-37, 111-39, and 111-53) containing intracytoplasmic inclusions on light microscopic examination. These were then deparaffinized, postfixed in 2.5% buffered glutaraldehyde followed by 1 % buffered osmium tetroxide, dehydrated, and embedded in epoxy resin (Epon) and examined with an electron microscope. 
Irnrnunoblot Analysis of Brain Extracts
Prion Protein Irnrnunocytocbernistry
Paraffin sections from frontal, temporal, and parietal cortices, hippocampus, and cerebellum from all 6 family members were treated with 98% formic acid and hydrolytic autoclaving to enhance PrP immunoreactivity [13] . Sections were then incubated with monoclonal antibody 3F4 raised against hamster PrP. The peroxidase-antiperoxidase method was used.
Results
Clinical Characterization
T h e clinical histories of the 6 members reported here have been summarized 11, 21. The clinical findings in a typical index patient (111-37) are briefly presented.
A 52-year-old woman (111-37) presented with progressive personality change and dementia. She complained of losing things around the house and forgetting names and recent events. She had received a high school education and had worked as a phone receptionist. Past medical history was noncontriburory. Her father (11-8), paternal grandmother Her family noted behavioral changes, initially seen at her mother's funeral where she was unfriendly to other family members and tended to "shy away." She acted in a "childish but affable" manner and compulsively walked the same route daily. She had a decreased libido and a craving for sweets, gaining 90 pounds over 4 years.
At age 53 she was oriented to person, place, and time; was slow in calculations; and was able to recall only one out of three objects at 5 minutes. O n the Wechsler Adult Intelligence Scale-Revised (WAIS-R) she scored an I Q of 72, with a verbal score of 72 and a performance score of 67.
Speech was normal and her motor findings were normal without evidence of extrapyramidal dysfunction.
At age 54 she was alert, attentive, and oriented to person, place, and time. She repeated nine digits forward and four backward. She named 1 out of 10 pictured objects and body dCase IIJ-37 showed extensive remote hypoxic/ischemic changes of the hippocampus and cerebellum and is not included in the scores.
Neuropulhological Findings in Patients with Chromosome 17-Linked Dementiad
parts. Repetition was normal. Constructions were poor. At 5 minutes she recalled none of three objects. On the WAIS-R she produced a verbal I Q of 74 and a performance I Q of 65. She scored poorly on fund of general information and verbal abstract reasoning. Her behavior was childish and impulsive and she had difficulty following instructions. Cranial nerve findings were normal. A decreased arm swing, difficulry with rapid alternating movements, a positive glabellar tap, and bilateral palmomental responses were noted.
The following were normal: complete blood cell count, erythrocyte sedimentation rate, electrolytes, creatinine level, liver and thyroid function, electrocardiogram, coagulation screen, urinalysis, and cerebrospinal fluid (CSF), with a protein concentration of 45 mg/dl, glucose level of 59 mg/dl, 0 white blood cells, 1 red blood cell, and a CSF opening pressure of 150 mm HzO. The electroencephalogram was normal.
Computed tomography at the age of 58 years showed diffuse cerebral atrophy, especially prominent in the frontal and temporal lobes. Sequential regional cerebral blood flow studies performed at ages 55, 56, and 57 revealed an initial decrement in cerebral blood flow affecting the frontal lobes, with later development of hypoperfusion of the posterior lobes.
Dementia progressed and was accompanied by slowing of movements with a stiff, shuffling gait. Eventually swallowing difficulties with drooling and muteness developed. By 59 years, she was bed bound and incontinent. Contractures of the elbows, knees, and hips had developed. Full extraocular movements were present. Reflexes were symmetrical and plantar reflexes were flexor. She followed no commands and remained mute, apart from groaning and grimacing in response to painful stimuli. She died at age 60.
Neuropatho Logy GROSS FINDINGS. Brain weights of the 6 patients ranged from 970 to 1,350 gm. Gyral atrophy was usually evident in anterior and inferior regions of the temporal lobes, the prefrontal areas, and the anterior cingulate gyrus, whereas the posterior frontal, parietal, and occipital areas appeared normal. The hippocampus appeared unremarkable. In the most severely affected members, the basal ganglia exhibited atrophy and mild brownish discoloration. T h e brainstem appeared normal, except for severe pallor of the substantia nigra in all members. T h e cerebellum was not remarkable.
MICROSCOPIC FINDINGS. Although the severity of histopathological changes varied from brain to brain, their distribution appeared uniform. In the most severely affected cortical areas, neuronal loss and gliosis were seen throughout the thickness of the cortex (Fig 1) . In less severely affected areas of cerebral cortex, the second, third, and sixth layers appeared to be primarily involved, with relative sparing of the fourth and fifth layers (Fig 2) . Generally, the astrogliosis seemed to exceed the severity of neuronal loss (see Table) . The atrophy of the superficial cortical layers was associated with laminar spongiosis commonly confined to the contigu- ous deep and superficial parts of the first and second layers (see Fig 1) . The most severely affected areas of the cerebral cortex were, in descending order, the prepiriform, anterior temporal, entorhinal, visual association (area 18), anterior cingulate, prefrontal, and insular regions (see Table) . The white matter underlying the most severely affected cortices showed axonal loss, myelin pallor, and mild isomorphic astrogliosis with relative sparing of the U fibers. Clustering of astroglial elements was not seen in subcortical areas (see Fig 2) .
T h e posterior cingulate gyrus, parietal cortex (available from 3 members), and visual cortex (area 17) (available from 5 members) did not show neuronal loss or significant gliosis. T h e motor cortex, available from only one of the most severely affected patients (111-35), showed no neuronal loss or gliosis. In all specimens, a striking feature was the sharp demarcation between severely affected cortices and seemingly normal cortex. This was most pronounced between the anterior cingulate gyrus and the medial frontal cortex (Fig 3 ) , and between areas 18 and 17 of the occipital cortex. Affected areas showed occasional ballooned neurons and spheroids. The latter appeared to correlate with the severity of the cortical changes. The hippocampal formation showed relative sparing with no or only mild neuronal loss in cornu ammonis CA1 to CA3, subiculum, and prosubiculum. Severe gliosis and axonal loss affected the perforant tract (Fig 4) and the molecular layer of the dentate fascia. There was mild neuronal loss and gliosis of the dentate fascia also involving the adjacent areas of CA4. In 1 patient (111-39), abnormalities in the hippocampus were confounded by extensive remote hypoxic/ischemic loss of pyramidal neurons (see Table) .
The most severely affected subcortical structures were, in descending order, the amygdala, substantia nigra (Fig 5) , ventral globus pallidus, periaqueductal gray, ventral putamen, ventral hypothalamus, and caudate nucleus (see Table) . The locus ceruleus, available from 4 members, showed mild neuronal loss and gliosis. The pontine nuclei were unremarkable, the red nucleus was only mildly affected, and the thalamic nuclei and substantia innominata were minimally involved. In all specimens, the basal ganglia showed a gradient in the severity of neuronal loss and gliosis. The rostra1 and ventral parts of the caudate nucleus, nucleus accumbens, putamen, medial pallidum, and claustrum were most severely affected by neuronal loss and gliosis, whereas the caudal and dorsal parts of the basal ganglia appeared virtually normal.
Mild neuronal loss was found in the inferior olivary nucleus and dorsal vagus nucleus. The cerebellar dentate nucleus and cortex appeared normal (see Table) .
Mild to moderate loss of motor neurons and gliosis was found in 2 (111-39 and 111-53) o f 3 members from The hippocampus and cerebral cortex showed insignificant numbers of neurofibrillary tangles or neuritic plaques of the Alzheimer type (see Table) . No Lewy bodies were demonstrated in any of the samples.
In all 6 family members, argyrophilic neuronal cytoplasmic inclusions were seen in several subcortical structures, most commonly in the third nerve nucleus (Fig 6) , followed by the dorsal raphe nucleus, ventral hypothalamus, subthalamic nucleus, periaqueductal gray, pars compacta of the substantia nigra, red nucleus, and globus pallidus, The inclusions stained intensely with Bielschowsky's silver impregnation and appeared by light microscopy to be composed of haphazardly arranged spicules (see Fig 6) .
In addition, oligodendroglial argyrophilic tangle-like inclusions were seen in the white matter, the external capsule, ansa lenticularis, corpus callosum, and brainstem.
Mild congophilic angiopathy was found in meningeal vessels of the occipital and parietal lobes in 1 brain (111-35).
1MMUNOCYTOCHEMlCAL FINDINGS. The subcortical neuronal inclusions stained positive for phosphorylated neurofilament (see Fig 6) and ubiquitin, whereas they were negative for beta-amyloid and tau and were therefore considered non-AD tangles. Occasional tau-and beta-amyloid-positive tangles were considered AD tangles (see Table) . Ballooned neurons stained positive for phosphorylated neurofilaments and variably positive for ubiquitin and tau. In areas of cortical neuronal loss and gliosis, numerous ubiquitin-positive and to a lesser degree, tau-positive granules and spheroids were seen.
The oligodendroglial argyrophilic inclusions stained positive for ubiquitin and tau (Fig 7) , whereas they were negative for beta-amyloid, phosphorylated neurofilament, and GFAP. dimensional lattice-like arrangement with a variable periodicity (Fig 8) . The inclusions demonstrated in oligodendroglial cells showed parallel tubular structures measuring approximately 14 to 17 nm in diameter.
IMMUNOBLOT ANALYSIS. Western blot analysis of brain extracts from the cerebellum of 1 member (III-35) failed to detect protease-resistant PrP (Fig 9) . PRION PROTEIN. No immunoreactive deposits of PrP were detected in any of the sections from the 6 brains.
Discussion
The degree of cerebral atrophy varied among family members. The prefrontal and anterior temporal lobes were severely and consistently affected, with a striking preservation of the hippocampal formation. The atrophy was symmetrical and showed a knife edge-like pattern in severely affected areas. The characteristic pathological changes were neuronal loss, astrogliosis, and laminar spongiosis of the limbic and association cortices, often in a sharply circumscribed fashion. Similar changes also involved various subcortical structures.
The most striking finding consisted of neuronal intracytop!asmic inclusions consisting of hitherto undescribed phosphorylated neurofilaments arranged in lattice-like formations. They were common in brainstem nuclei, hypothalamus, and basal ganglia. Their distribution was similar to that of tangles in progressive su- The distribution of the present changes suggests involvement of cortical and subcortical structures encompassing cortico-basal ganglionic circuits such as the entorhinal, anterior temporal, and cingulate projections to the ventral striatum [25, 261 , as well as projections from the piriform cortex and amygdala to the ventral hypothalamus, entorhinal cortex, and temporal association cortex [25, 261. Furthermore, involvement of the mesolimbic system may be postulated, involving projections from the ventral tegmental area of the substantia nigra to the anterior cingulate, entorhinal, and insular cortices 127-291.
The severe involvement of the anterior temporal cortex, including the amygdala, is likely to correlate with the personality changes characterized by hyperorality and hypo/hypersexuality consistent with the KliiverBucy syndrome [30, 311 . The changes of prefrontal cortex and apparent deafferentation of the hippocampal formation are most likely responsible for the frontal lobe release signs, frontal lobe dementia, and eventually global dementia. The profound degeneration of the substantia nigra corresponds to the parkinsonian signs exhibited early in the course of the disease. The prefer-
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ential involvement of the ventral striatum is most likely associated with the pathology in the association cortices and neocortical limbic structures [25, [54] [55] [56] [57] .
The disorders that demonstrate similarities with Ch-17D, and therefore should be considered in the differential diagnosis, include PSG, CBD and FLD and its subtypes [44] . Sporadic and familial PSG shows preferential involvement of white matter, usually most severe in the frontal lobe [9, 401, variably asymmetrical (9, 581, and without sharp demarcation between affected and unaffected cortices [9] . PSG shares with the present disease severe involvement of the substantia nigra, and sparing of the hippocampus and cortical astrogliosis exceeding that expected from the degree of neuronal loss [4, 91. However, in the brains studied here, subcortical gliosis, the hallmark of PSG, was absent. In contrast to the familial PSG patients reported by Lanska and colleagues [ 91, the present family members showed uniformly moderate to severe involvement of the rostroventral basal ganglia, including ventromedial pallidum and amygdala. Perhaps the most striking pathological differences between Ch-17D and PSG were the presence of intraneuronal inclusions and GCIs in Ch-17D. Petersen CBD is a discrete clinicopathological entity. The neuropathological abnormalities include frontoparietal atrophy with relative sparing of the temporal lobe, ballooned neurons within the cerebral cortex, and variable degeneration of subcortical structures, most consistently affecting the substantia nigra [21,46, and associates (2 I) also demonstrated involvement of the rostra1 internal and external segments of the globus pallidus, putamen, and caudate nucleus, similar to the pathology reported here. The same authors demonstrated GCIs and subcortical neurofibrillary tangles of the PSP type, and hence different from those reported here [ 171. The present entity therefore shows considerable overlap with CBD, although differences exist in the involvement of the parietal and temporal lobes, and the asymmetrical involvement of the pathology in CBD [21] . Whether the two entities are genetically linked remains to be investigated, although substantial clinical differences exist. CBD starts at a later age and has a more rapid course [21, 461.
The cortical changes in Ch-17D are similar to those in FLD, although the parietal lobe and the hippocampus are commonly involved in the latter [43, 441 , and FLD lacks the neuronal and glial inclusions described here.
Despite substantial overlap in pathology with several degenerative dementing disorders, we conclude that the present disease shows several distinguishing features, such as sharply circumscribed cortical atrophy involving limbic structures and association cortices, unique intraneuronal inclusions, and lack of subcortical gliosis, to regard it, for now, as a separate pathological entity. Further genetic analyses of patients with CBD, FLD, PPND, or classic Picks disease will be of interest in determining whether these diseases are genetically distinct or whether they are linked to chromosome 17 as are the present disease and PSG [4] . In summary, we described the pathology in a familial progressive dementing disorder, clinically characterized as disinhibition-dementia-parkinsonism-amyotrophy complex [I] . Study of 6 available brains showed a uniform distribution of neuropathological changes. The clinical and pathological distinctions between multisystem degenerations may at times be difficult, and overlapping syndromes may be etiologically related [4, 32, 381. Their etiological relationship will require determination of the molecular basis for these conditions. For simplicity and in keeping with the genetic characterization of the present disorder, we suggest that the clinical and pathologic entity be called "chromosome 17-linked dementia."
